Bacterial genome engineering and synthetic biology: combating pathogens

Area of Science:

• Microbiology
• Genetics
• Synthetic Biology

Background:

• Multidrug-resistant (MDR) bacteria pose a significant global health threat, complicating treatment of common infections.
• The rise of MDR infections, reported by WHO and CDC, necessitates urgent action to understand and combat drug resistance mechanisms.
• Antimicrobial resistance creates an economic burden, prompting global initiatives to improve awareness and understanding.

Purpose of the Study:

• To review the application of bacterial genome engineering and synthetic biology (SB) tools for combating MDR pathogens.
• To highlight advances in genetic engineering for targeting and editing bacterial genomes to understand drug resistance.
• To discuss the potential of SB technologies in developing novel antibacterial strategies.

Main Methods:

• Review of current literature on genome engineering tools like recombineering and CRISPR.
• Analysis of bacterial cell-cell signaling mechanisms for pathogen targeting.
• Exploration of synthetic biology applications in antibacterial strategy development.

Main Results:

• Genome engineering and SB tools show promise for diagnosing and treating recalcitrant bacterial infections.
• These technologies can aid in understanding and mitigating bacterial drug resistance mechanisms.
• Applications include novel antibiotic production, phage therapy, diagnostics, and vaccine development.

Conclusions:

• The increasing prevalence of MDR bacteria highlights the urgent need for novel therapeutics.
• Synthetic biology offers promising solutions for developing safe and effective antibacterial therapies.
• Advanced genome engineering and SB tools are crucial for addressing the challenge of antimicrobial resistance.